Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Cipla, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cipla.

    • Cipla can rally to Rs 355-360: Atul Badkar

      Cipla can rally to Rs 355-360, says Atul Badkar of Edelweiss Securities.

    • Sukhani upbeat on Dr Reddys Labs, Lupin, Cipla

      Sudarshan Sukhani of s2analytics.com is upbeat on Dr Reddys Laboratories, Lupin, Cipla.

    • Buy Cipla, Hero Motocorp: Mohindar

      Buy Cipla and Hero Motocorp at current levels, says Rahul Mohindar, Director, viratechindia.com.

    • Cipla, Sintex Ind likely to move up: SBICAP Sec

      Jitender Kumar, SBICAP Securities is of the view that Cipla has target of Rs 370.

    • Dr Reddys Lab has target of Rs 1575: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Dr Reddys Laboratories has target of Rs 1575.

    • Buy Cipla, Tata Motors (DVR) on any dips: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cipla, Tata Motors (DVR) on any dips.

    • Buy Apollo Tyres, Cipla, Ranbaxy: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can bet on Apollo Tyres, Cipla, Ranbaxy.

    • Hold Cipla, says Rakesh Bansal

      Rakesh Bansal of rakeshbansal.com is of the view that one should hold Cipla.

    • Cipla, TCS, Mphasis safe bets: Sukhani

      Sudarshan Sukhani, s2analytics.com is of the view that Cipla, TCS, Mphasis are safe bets.

    • Sukhani's view on pharma, auto stocks

      Sudarshan Sukhani of s2analytics.com view on pharma and auto stocks.

    • 6 stock ideas to liven up your trade

      On CNBC-TV18's show Super Six, market gurus Vishal B Malkan, CMT, www.malkansview.com, Parag Doctor of Keynote Capitals and Rajesh Jain, EVP Retail Research, Religare Sec, Technical Analyst, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Cipla can touch Rs 350: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com feels that Cipla can touch Rs 350.

    • 6 trading stocks for short term gain

      On CNBC-TV18's show Super Six, market gurus Parag Doctor of Keynote Capitals, Vishal B Malkan, CMT, www.malkansview.com and Nooresh Merani of AMSEC Research, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Cipla, Lupin good bets in pharma space: Diwan

      Cipla and Lupin are good trading bets in pharma space, says Prakash Diwan, Asit C Mehta Investment.

    • Stay invested in Cipla: Thunuguntla

      Stay invested in Cipla, says Jagannadham Thunuguntla, Strategist & Head of Research at SMC Global Securities.

    • Sell Cipla, says Sudarshan Sukhani

      Sell Cipla, says Sudarshan Sukhani of s2analytics.com.

    • Cipla may move up, says Rajen Shah

      Cipla may move up from current levels, says Rajen Shah, CIO, Angel Broking.

    • Buy Larsen and Toubro, says Sukhani

      Buy Larsen and Toubro (L&T), says Sudarshan Sukhani of s2analytics.com.

    • Buy Cipla on dips: Sukhani

      Buy Cipla on dips, says Sudarshan Sukhani, s2analytics.com.

    • Buy Raymond, says Sudarshan Sukhani

      Buy Raymond, says Sudarshan Sukhani, s2analytics.com.

    • Keep stoploss at Rs 22 in GMR Infra: Sukhani

      Keep stoploss at Rs 22 in GMR Infra, says Sudarshan Sukhani, s2analytics.com.

    • Buy Cipla, sell GAIL: Sudarshan Sukhani

      Buy Cipla and sell GAIL at current levels, says Sudarshan Sukhani, s2analytics.com.

    • Super Six stocks you can bet on Jan 06

      On CNBC-TV18's show Super Six, market gurus Rajesh Jain of Religare Securities, Arunesh Madan of Augment Investment Pvt Ltd and Vishal Kshatriya of Edelweiss, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Super Six stocks you can bet on Dec 28

      On CNBC-TV18's show Super Six, market gurus Hemen Kapadia CEO chartpundit.com, Vishal B Malkan, CMT, www.malkansview.com and Nooresh Mirani - AVP Technical, AMSEC Research, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347